Fujifilm Medical Systems U.S.A., Inc. has received FDA clearance for six different endoscopic imaging solutions.
The solutions included in this round of approvals include:
- The ED-580XT duodenoscope
- The EI-580BT short double balloon endoscope
- The EC-760P and EC-760S colonoscopes
- The EG-760CT and EG-740N gastroscopes
“As a company with many ‘firsts’ in the endoscopy space, our goal is to always stay a step ahead, anticipate clinician needs and continue to advance the field,” Taisuke Fujita, general manager of Fujifilm Medical Systems U.S.A., Inc., said in a prepared statement. “Physicians perform more than 51 million gastrointestinal endoscopic procedures annually, and Fujifilm’s latest innovations are engineered to support them during even the most sophisticated procedures and interventions to ultimately enhance patient care.”
“The six recent FDA clearances on Fujifilm’s core GI and interventional endoscopes rounds out our portfolio, enabling us to serve the growing demands of hospitals across the US,” Jason Heim, vice president of sales for FUJIFILM Medical Systems U.S.A., Inc., said in the same statement. “Built upon our legacy of high-performance healthcare innovations and a more comprehensive portfolio than ever before, Fujifilm is well positioned to meet the demands of today’s busy health care systems. Our scope of solutions has never been stronger.”
The FDA cleared the ED-580XT duodenoscope earlier in 2019, according to the statement, but Fujifilm included it as a key part of this wave of approvals.